Price alert —
Sign in to get a one-time email the moment BAYRY crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · BAYRY
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13.4B | $2.8B | $3.5B | $-2.2B | 20.6% | 26.3% |
| 2025-12-31 | $11.4B | $-3.8B | $4.3B | $3.4B | -32.8% | 38.0% |
| 2025-09-30 | $9.7B | $-1.0B | $-0.5B | $0.8B | -10.0% | -5.6% |
| 2025-06-30 | $10.7B | $-0.2B | $0.0B | $0.6B | -1.9% | 0.1% |
| 2025-03-31 | $13.7B | $1.3B | $2.3B | $-1.4B | 9.5% | 16.9% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare BAYRY vs peers
Line BAYRY up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
BAYRY
BAYRY
$13.80
+1.47%
JNJ
JNJ
$253.04
+1.23%
AVGO
Broadcom Inc.
$370.83
-0.97%
Earnings replay · last 0 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
No earnings history available.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| BAYRY ★ | $54B | — | 11.1 | 1.2 | 8.5 | 1.6 | 59.9% | -2.4% | 112.9% | 13.49% |
| LLY | — | 43.9 | — | — | — | — | — | 55.5% | — | 0.84% |
| UNH | $387B | 31.8 | 19.2 | 0.9 | 20.2 | 4.0 | 18.8% | 2.0% | 0.7% | 4.57% |
| JNJ | $609B | 29.0 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.8 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 0.17%
| Holder | Shares | % out |
|---|---|---|
| Kahn Brothers Group Inc. | 6,513,893 | 0.17% |
| Westside Investment Management, Inc. | 2,878 | — |
| PNC Financial Services Group, Inc. | 3,030 | — |
| Atlas Capital Advisors Inc | 35,510 | — |
| Great Lakes Advisors LLC | 119,517 | — |
| Rhumbline Advisers | 68,123 | — |
| Salomon & Ludwin, LLC | 2,141 | — |
| Gamma Investing LLC | 41,204 | — |
| Chicago Trust Co Na | 20,097 | — |
| Sterling Capital Management, LLC | 846 | — |
Insider activity · 90d
No insider trades for BAYRY in last 90d.
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
No CIK found for BAYRY.
About BAYRY
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmaci…
Options picks · BAYRY
ITM + OTM ideas from the latest scanLoading…
Congress trades · BAYRY
STOCK Act disclosuresLoading…
SEC filings & insiders · BAYRY
EDGAR · liveLoading…
Holders · BAYRY
Institutions & insider activityLoading…